Global food and beverage companies from PepsiCo to Coca-Cola are focusing on shorter ingredient lists and smaller pack sizes in 2026 as more people take appetite-suppressing GLP-1 drugs for weight loss.

Add Reuters to Your Google Preferred Sources

 

Reuters Business

Reuters Business

 

Big Food pours millions into rebrands as obesity drugs reshape US demand 

 

Meta's Zuckerberg faces questioning at youth addiction trial 

 

Bayer retreats as investors sour on deal to settle Roundup litigation 

 

Morning Bid: Changing of Lagarde 

 

ECB President Lagarde plans to quit before Macron's term ends, FT reports 

 

US stock futures rise as tech concerns subside 

 

Walmart to tread with caution into 2026 as Furner-era begins 

 

Thyssenkrupp could divest materials trading division as soon as 2026, sources say 

 

Sun, sand and empty beaches: Trump oil squeeze chokes Cuba's tourism 

 

UBS lifts forecast for big tech bond sales this year 

 

Sponsors are not involved in the creation of newsletters or other Reuters news content. Advertise in this newsletter or on Reuters' website

LiveIntent Logo
AdChoices Logo
 

Reuters Business is sent every weekday. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here.

Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here.

This email includes limited tracking for Reuters to understand whether you’ve engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement.

Terms & Conditions

 

© 2026 Thomson Reuters. All rights reserved.
3 Times Square, New York, NY 10036

fb ig x